Shrateh Oadi N, Saa Shadi Abu
Faculty of Medicine, Al-Quds University, Jerusalem, Palestine.
Faculty of Medicine, Al-Quds University, Jerusalem, Palestine; Department of Neurosurgery, Palestinian Medical Complex (PMC), Ramallah, Palestine.
Int J Surg Case Rep. 2023 Oct;111:108819. doi: 10.1016/j.ijscr.2023.108819. Epub 2023 Sep 13.
The occurrence of brain metastasis due to cholangiocarcinoma is an exceedingly uncommon phenomenon, documented in only a few numbers of published cases. Recent studies indicated an incidence rate of just 0.15 % for brain metastases in connection with this condition, which was also linked to a reduced survival rate.
A 58-year-old woman with a history of hepatobiliary cholangiocarcinoma presented with a recent onset of unsteady walking, dizziness, vomiting, and worsening occipital headaches. Her medical history included successful chemotherapy treatment for her cholangiocarcinoma. Neurological examination revealed right-sided cerebellar deficits, and imaging indicated a sizable lesion in the right cerebellar hemisphere with surrounding vasogenic edema. A PET scan revealed a liver lesion but no other significant abnormalities. The recommended approach was surgical excision of the cerebellar lesion to relieve symptoms, halt deterioration, and obtain a tissue sample for analysis. After comprehensive discussions with the patient and her family, they opted for the surgical procedure.
The major contributors to brain metastases include lung cancers, breast cancers, testicular cancers, melanomas, and renal tumors. In contrast, brain metastases originating from gastrointestinal cancers are less frequent, accounting for fewer than 4 % of cases, with notable impact on 1 % of colorectal cancers, 0.62 % of gastric cancers, and 0.33 % of pancreatic cancers. However, brain metastases are extremely rare.
This study underscores the significance of anticipating and identifying brain metastases in biliary tract cancers, even in the face of their low incidence and the limited amount of available literature on the subject.
胆管癌导致脑转移是一种极为罕见的现象,仅有少数已发表病例记载。近期研究表明,与此病症相关的脑转移发生率仅为0.15%,这也与生存率降低有关。
一名58岁有肝胆管癌病史的女性,近期出现行走不稳、头晕、呕吐及枕部头痛加重症状。她的病史包括胆管癌化疗成功。神经系统检查发现右侧小脑功能缺损,影像学检查显示右侧小脑半球有一个较大病变,周围伴有血管源性水肿。PET扫描显示肝脏有一个病变,但无其他明显异常。建议的治疗方法是手术切除小脑病变以缓解症状、阻止病情恶化并获取组织样本进行分析。在与患者及其家属进行全面讨论后,他们选择了手术治疗。
脑转移的主要病因包括肺癌、乳腺癌、睾丸癌、黑色素瘤和肾肿瘤。相比之下,源自胃肠道癌症的脑转移较少见,占病例不到4%,对1%的结直肠癌、0.62%的胃癌和0.33%的胰腺癌有显著影响。然而,脑转移极为罕见。
本研究强调了在胆管癌中预测和识别脑转移的重要性,即使其发生率较低且关于该主题的现有文献有限。